The global oncology adjuvants market is on a steady trajectory, poised to surpass a valuation of USD 829.86 Million by 2032, according to recent market analysis. At the close of 2021, the market was valued at approximately USD 506.01 Million, with a projected Compound Annual Growth Rate (CAGR) of 4.60%. The surge in cancer cases …
Continue reading “Global Oncology Adjuvants Market Set to Reach USD 829.86 Million by 2032”